Newly launched Afya App, through a partnership between a German-based pharmaceutical firm Boehringer Ingelheim and Kenyan PharmAccess, is aimed at enabling diabetes and hypertension patients in treatment and management of the disease.
Practically the program allows patients to monitor their blood pressure and blood glucose levels at their convenience at home, digitally sending the results to their doctor for review.
The new program aims at addressing an unmet need for efficient affordable and widely accessible care for hypertension and diabetes in Kenya.
Using M-TIBA a product of PharmAcess, funds will be placed in specialized health wallets though MPesa and their use will be restricted to spending at healthcare providers who form part of a nationwide M-TIBA network.
Currently, more than 1,800 healthcare providers have signed up across Kenya.